Condition

ATTR Amyloidosis clinical trials and research

As of November 12, 2026, Find a Trial lists 4 ATTR Amyloidosis clinical trials that are recruiting, at sites in 18 countries (most in Italy (3), Denmark (2), Germany (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest ATTR Amyloidosis clinical trials

StudyPhaseWhereStatusRegistered
Hungarian National Systemic Amyloidosis Registry — Balatonfüred and 11 other locations Recruiting Jul 8, 2026
Understanding the characteristics and treatment of patients with ATTR amyloidosis — Eden Prairie, Minnesota and 28 other locations Recruiting Apr 10, 2024
Registry for patients with ATTR amyloidosis — Legnano, MI and 29 other locations Recruiting Jul 6, 2022
Observational study of patients with ATTR amyloidosis — La Jolla, California and 39 other locations Recruiting Sep 23, 2020

All recruiting trials (4)

Related topics

AL AmyloidosisAmyloid CardiomyopathySystemic Amyloidosis

Quick answers

How many ATTR Amyloidosis clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in Italy (3 trials), Denmark (2 trials), Germany (2 trials), Portugal (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.